Soft Launching of the Electronic Philippine National Formulary (ePNF)
In the interest of providing our health facilities with an up-to-date online reference on the essential medicines approved for procurement by all government procuring entities and reimbursement by the PhilHealth, the Department of Health (DOH), through the Pharmaceutical Division (PD), is currently transforming the Philippine National Formulary (PNF) into an electronic version named as the Electronic PNF (ePNF).

In this regard, we enjoin all stakeholders to visit the newly-developed ePNF and to submit comments and/or feedback to further improve the electronic system through the survey form until 20 July 2022.

The ePNF is accessible through https://pnf.doh.gov.ph while the feedback form may be accessed through https://tinyurl.com/ePNF-survey
Strategic Framework and Implementing Guidelines of the Philippine Medicines Policy 2022-2030
DOH Showcased “Malasakit at Aksyon” in the 1st face to face Policy Dialogue Since 2019
Program implementation review and updates on the different programs of the pharmaceutical division
Duterte Legacy Summit highlights DOH efforts on setting Maximum Retail Price for high-cost medicines
1st Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Devices List (PEMDL)

Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.

//
August 2, 2022

After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.

//
June 10, 2022

The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.

//
June 1, 2022

The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.

//
June 1, 2022

A successful initial collaboration of the DOH Pharamceutical Division – Medical Device Unit spearheaded by Dir. Anna Melissa S. Guerrero, MD, MPH (HTA) and Dr. Constante Caluya III, MBA and their Expert Advisory Committee for medical devices and supplies led by Dr. Ronaldo H. Estacio, together with the Health Technology Assessment Division headed by Ms. Anne Julienne Genuino-Marfori, RPh, MSc and their Health Technology Assessment Council chaired by Dr. Marita V. Tolentino-Reyes.

//
May 20, 2022

Advisories

Events

Philippine Standard time

Contact Us:

Telephone Number: 02-8757734 Loc. 253

Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City

Email Address: pharmareceiving@doh.gov.ph